Results 91 to 100 of about 80,628 (257)
Based on individualized design for critical bone defect, biological bone is cut by subtractive manufacturing, sintered into biological hydroxyapatite (BHA) scaffolds, and masked with extracellular matrix‐gelatin hydrogel (ECM‐gel) to prepare gelatin hydrogel‐masked BHA (G‐BHA) scaffolds.
Jieyun Xu+12 more
wiley +1 more source
Internal fibrinolysis of fibrin clots is driven by pore expansion
Blood clots, which are composed of blood cells and a stabilizing mesh of fibrin fibers, are critical in cessation of bleeding following injury. However, their action is transient and after performing their physiological function they must be resolved ...
Rebecca A. Risman+5 more
doaj +1 more source
Fibrinolysis can be used to improve fluid drainage in pleural infection. Treatment with either urokinase or tissue plasminogen activator (t-PA) in association with DNAse via a chest tube has been effective at reducing the need for surgery.
Benoît Bédat+6 more
doaj +1 more source
Enhanced Fibrinolysis with Magnetically Powered Colloidal Microwheels.
Thrombi that occlude blood vessels can be resolved with fibrinolytic agents that degrade fibrin, the polymer that forms between and around platelets to provide mechanical stability.
T. Tasci+6 more
semanticscholar +1 more source
Various properties of bone biomaterials can modulate components of the blood clot (including the fibrin network, red blood cells, platelets, and the complement system) in vivo implantation, leading to the formation of a biomaterial–blood clot complex (BBCC) significantly impacting subsequent osteoimmunomodulation.
Zongpu Han+11 more
wiley +1 more source
Global fibrinolysis assays detect the fibrinolysis time of clot dissolution using tissue-type plasminogen activator (tPA). Two such assays, clot-fibrinolysis waveform analysis (CFWA) and global fibrinolysis capacity (GFC) assay, were recently developed ...
Takumi Tsuchida+2 more
doaj +1 more source
Background: The role of intrathecal fibrinolysis for the treatment of patients with aneurysmal subarachnoid hemorrhage (aSAH) has been widely investigated; however, the results have been contradictory.
Xiaocheng Lu+6 more
doaj +1 more source
Despite the common use of thrombolytic drugs, especially in stroke treatment, there are many conflicting studies on factors affecting fibrinolysis. Because of the complexity of the fibrinolytic system, mathematical models closely tied with experiments ...
Brittany E. Bannish+4 more
semanticscholar +1 more source
Disseminated intravascular coagulation (DIC) is the most frequent coagulation disorder associated with metastatic prostate adenocarcinoma. However, DIC with enhanced fibrinolysis as an initial presentation of prostate cancer is extremely rare.
Mónica Palma Anselmo+4 more
doaj +1 more source
Warfarin and fibrinolysis - a challenging combination: an observational cohort study
Background Patients presenting with ST-segment elevation myocardial infarction (STEMI) frequently use warfarin. Fibrinolytic agents and warfarin both increase bleeding risk, but only a few studies have been published concerning the bleeding risk of ...
Luurila Harri+5 more
doaj +1 more source